ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast CancerSuneel Kamath,David Tai,Irene Moreno,Hani Babiker,Zhaohui Jin,Changhoon Yoo, Fabien Ricard,Kai Yu Jen, Jim Coward,Jia Liu,Frans Opdam,Michael Millward,Mariano Ponz-Sarvise,Jeffrey Yachnin,Richard Kim,Joon Oh Park,Vivek Subbiah,Alison M. SchramCANCER RESEARCH（2023）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
